Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Nigel Langley

The Power List 2021 – Small Molecules


Global Technology Director at BASF

Langley has written over 100 scientific publications and co-edited two books. He is also an adjunct professor at the University of Mississippi and a Fellow of the UK’s Royal Society of Chemistry. In 2018, he was awarded the Industry Research Achievement Award in Excipient Technology by the IPEC Foundation. He has been a member of the Executive Committee at IPEC Americas since 2010 and is currently Chair Elect. He is also helping to lead the Novel Excipients Initiative for IPEC Americas in collaboration with the IQ Pharma Consortium. “I have a passion and interest in innovation especially in the area of pharmaceutical excipients. I am hopeful that, in the coming years, excipient innovation will become a key driver in the pharmaceutical industry, in both biologics and small molecule drug development. Without the opportunity to develop new excipients that have been specifically designed to help address current and future formulation challenges – for example, in improving the stability of biologics and in the area of poorly soluble small molecules – these challenges will remain unmet and, as a consequence, optimal medicines will not be available to the patient.”


Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register